Prowpanga Udompap

470 total citations
22 papers, 341 citations indexed

About

Prowpanga Udompap is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Prowpanga Udompap has authored 22 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Hepatology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Prowpanga Udompap's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (11 papers) and Liver Disease and Transplantation (7 papers). Prowpanga Udompap is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (11 papers) and Liver Disease and Transplantation (7 papers). Prowpanga Udompap collaborates with scholars based in United States, Thailand and South Korea. Prowpanga Udompap's co-authors include W. Ray Kim, Donghee Kim, Ajitha Mannalithara, Nae‐Yun Heo, Joanne T. Benson, Ananya Pongpaibul, Alina M. Allen, Phunchai Charatcharoenwitthaya, Terry M. Therneau and Jane C. Tan and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Prowpanga Udompap

19 papers receiving 339 citations

Peers

Prowpanga Udompap

EPIDE

HEPAT

SURGE

PFM

EDM

Naglaa Allam Egypt

Sumeyye Samur United States

Carmen Landaverde United States

Zita Galvin Canada

Ezequiel Mauro Spain

Thinesh Lee Krishnamoorthy Singapore

Aymin Delgado‐Borrego United States

Alisa Likhitsup United States

Eunice Xiang‐Xuan Tan Singapore

Tamoore Arshad United States

Naglaa Allam Egypt

Prowpanga Udompap

259 ×0.9

EPIDE

272 ×1.1

HEPAT

61 ×1.3

SURGE

7 ×0.3

PFM

10 ×0.5

EDM

Citations per year, relative to Prowpanga Udompap Prowpanga Udompap (= 1×) peers Naglaa Allam

Countries citing papers authored by Prowpanga Udompap

Since Specialization

Citations

This map shows the geographic impact of Prowpanga Udompap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prowpanga Udompap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prowpanga Udompap more than expected).

Fields of papers citing papers by Prowpanga Udompap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prowpanga Udompap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prowpanga Udompap. The network helps show where Prowpanga Udompap may publish in the future.

Co-authorship network of co-authors of Prowpanga Udompap

This figure shows the co-authorship network connecting the top 25 collaborators of Prowpanga Udompap. A scholar is included among the top collaborators of Prowpanga Udompap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prowpanga Udompap. Prowpanga Udompap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Udompap, Prowpanga. (2025). 2D-SWE in MASLD: Should we utilize it more with these new cutoffs?. Hepatology. 82(2). 281–282.

Udompap, Prowpanga. (2025). Resmetirom: Steatosis Down, Fibrosis Out, Peace of Mind In. Hepatology. 81(4). 1105–1106.

Udompap, Prowpanga, Kan Liu, Zachi I. Attia, et al.. (2024). Performance of AI-Enabled Electrocardiogram in the Prediction of Metabolic Dysfunction–Associated Steatotic Liver Disease. Clinical Gastroenterology and Hepatology. 23(4). 574–582.e3. 6 indexed citations

Sripongpun, Pimsiri, Apichat Kaewdech, Prowpanga Udompap, & W. Ray Kim. (2024). Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score. JHEP Reports. 6(10). 101127–101127. 17 indexed citations

Sripongpun, Pimsiri, Prowpanga Udompap, Ajitha Mannalithara, et al.. (2023). Hepatitis C Screening in Post–Baby Boomer Generation Americans: One Size Does Not Fit All. Mayo Clinic Proceedings. 98(9). 1335–1344. 1 indexed citations

Udompap, Prowpanga, et al.. (2022). Viral Hepatitis Among African Immigrants with Hepatocellular Carcinoma in Minnesota: High Prevalence Yet Low Awareness. Journal of Immigrant and Minority Health. 25(2). 357–364. 1 indexed citations

Udompap, Prowpanga, et al.. (2022). Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population. Hepatology. 77(3). 931–941. 26 indexed citations

Udompap, Prowpanga & W. Ray Kim. (2020). Development of Hepatocellular Carcinoma in Patients With Suppressed Viral Replication: Changes in Risk Over Time. Clinical Liver Disease. 15(2). 85–90. 17 indexed citations

Udompap, Prowpanga, Tawesak Tanwandee, & Rino Alvani Gani. (2020). Affordability of Antiviral Therapy in Asia‐Pacific Countries and Its Impact on Public Health Outcomes. Clinical Liver Disease. 16(6). 249–253. 4 indexed citations

10.

Chesdachai, Supavit, et al.. (2019). Pulmonary Mycobacterium Spindle Cell Pseudotumor in Patient With Liver Transplant. The American Journal of the Medical Sciences. 359(1). 42–50. 2 indexed citations

11.

Udompap, Prowpanga, et al.. (2019). Prospective comparison of transient elastography, point shear wave elastography, APRI and FIB‐4 for staging liver fibrosis in chronic viral hepatitis. Journal of Viral Hepatitis. 27(4). 437–448. 32 indexed citations

12.

Wongjarupong, Nicha, Passisd Laoveeravat, Prowpanga Udompap, Kornpong Vantanasiri, & Caitlin Bakker. (2019). 992 Venous Thromboembolism Prophylaxis in Hospitalized Patients With Chronic Liver Disease and the Bleeding and Thrombosis Risk: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology. 114(1). S576–S577.

13.

Udompap, Prowpanga, Donghee Kim, Aijaz Ahmed, & W. Ray Kim. (2018). Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment. Alimentary Pharmacology & Therapeutics. 48(11-12). 1282–1289. 16 indexed citations

14.

Heo, Nae‐Yun, Ajitha Mannalithara, Donghee Kim, et al.. (2017). Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States. Transplantation. 102(3). 454–460. 30 indexed citations

15.

Kwong, Allison J., W. Ray Kim, Ajitha Mannalithara, et al.. (2017). Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States. Liver Transplantation. 24(6). 735–743. 18 indexed citations

16.

Udompap, Prowpanga, et al.. (2017). An Alternative Screening Strategy for Hepatitis C Virus (HCV) Infection Among Americans not Belonging in the Baby Boomer Birth Cohort. Gastroenterology. 152(5). S1078–S1078. 1 indexed citations

17.

Udompap, Prowpanga, Ajitha Mannalithara, Nae‐Yun Heo, Donghee Kim, & W. Ray Kim. (2016). Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection. Journal of Hepatology. 64(5). 1027–1032. 56 indexed citations

18.

Heo, Nae‐Yun, et al.. (2016). Decreasing Mortality in Liver Transplant Candidates with Hepatitis C Virus Infection in the United States. Journal of Hepatology. 64(2). S553–S553. 1 indexed citations

19.

Udompap, Prowpanga, Donghee Kim, & W. Ray Kim. (2015). Current and Future Burden of Chronic Nonmalignant Liver Disease. Clinical Gastroenterology and Hepatology. 13(12). 2031–2041. 107 indexed citations

20.

Udompap, Prowpanga, Ajitha Mannalithara, Nae‐Yun Heo, & W. Ray Kim. (2015). O120 : Advanced fibrosis is common in individuals whose hepatitis C has not been diagnosed: Results from the national health and nutrition examination survey 2001-2012. Journal of Hepatology. 62. S253–S254. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact